Biopharma Company Alvotech to Go Public in $2.25 Bln SPAC Deal Post author By Post date December 7, 2021 Biopharmaceutical company Alvotech Read MoreShare this:TwitterFacebookLike Loading... Tags analysis, business, business news, economy, economy news, finance, market analysis, market research, markets, news, world news ← Bottlenecks Add to Wage Pressure in Norway, C.bank Survey Finds → Radware and Oncore Cloud Services Join Forces to Help Organizations Protect Their Cloud Assets